文献速递消化与肝胆胰病理细胞病理与分子病理

COVID-19阳性患者胃肠道样本的病理学分析

Gastrointestinal Pathology in Samples From Coronavirus Disease 2019 (COVID-19)-Positive Patients.
PubMed 文献 · Arch Pathol Lab Med · 2021-01-01

5例在操作前7天内阳性,20例平均53天前阳性。胃肠道表现从正常到缺血性结肠,ISH/NGS阳性不一,无特异性组织学发现。

要点

  • COVID-19患者胃肠道标本可检出SARS-CoV-2,但无特异性组织学改变。
  • 近期感染(7天内)者部分ISH/NGS阳性,远期(平均53天)者ISH均阴性。
  • 缺血性结肠可继发于全身病毒效应,但组织内未必检出病毒。

核心结论

  • COVID-19患者胃肠道表现从正常到缺血性结肠不等,组织内病毒检出状态不一,无特异性组织学发现。

主要发现

  • 5例在胃肠道操作前7天内鼻咽拭子阳性,20例在操作前平均53天阳性。
  • 7天内阳性者中,1例结肠切除标本NGS阳性但ISH阴性,1例缺血性结肠ISH和NGS均阴性,1例末端回肠正常但ISH和NGS均阳性,1例回肠溃疡两者均阴性。
  • 20例远期阳性者中,所有标本ISH均阴性,但1例NGS阳性(其鼻咽拭子阴性)。

临床怎么用

  • 对COVID-19患者胃肠道标本,组织学表现无特异性,病毒检出需结合ISH和NGS,但阴性不能排除既往感染。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

CONTEXT.—: Although primarily considered a respiratory illness, coronavirus disease 2019 (COVID-19) can cause gastrointestinal manifestations. OBJECTIVE.—: To evaluate histopathology and in situ hybridization for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in gastrointestinal samples from patients with recent and remote COVID-19. DESIGN.—: Patients with positive SARS-CoV-2 nasopharyngeal tests and a gastrointestinal tissue specimen were included. SARS-CoV-2 in situ hybridization (ISH) was performed on each sample. A subset had SARS-CoV-2 next-generation sequencing (NGS) performed. RESULTS.—: Twenty-five patients met inclusion criteria. Five had positive SARS-CoV-2 nasopharyngeal tests within 7 days of their gastrointestinal procedure. Two were ulcerative colitis patients on steroid therapy who lacked typical COVID-19 symptoms. Their colectomies showed severe ulcerative colitis; one demonstrated SARS-CoV-2 by NGS but a negative ISH. Another had an ischemic colon resected as a complication of the COVID-19 course; however, both ISH and NGS were negative. A fourth had a normal-appearing terminal ileum but positive ISH and NGS. The fifth patient had ileal ulcers with SARS-CoV-2 negativity by both modalities. The remaining 20 patients had positive nasopharyngeal tests an average of 53 days prior to procedure. None of their samples demonstrated SARS-CoV-2 ISH positivity, but one was positive on NGS despite a negative nasopharyngeal test. CONCLUSIONS.—: Gastrointestinal findings from SARS-CoV-2-infected patients ranged from normal with virus detected by ISH and NGS to bowel ischemia secondary to systemic viral effects without evidence of virus in the tissue. No distinct histologic finding was identified in those with gastrointestinal tissue specimens demonstrating SARS-CoV-2 positivity in this cohort.

来源:Arch Pathol Lab Med,查看原文。版权归原作者所有。

引用

  1. Westerhoff M, Jones D, Hrycaj SM, et al. Gastrointestinal Pathology in Samples From Coronavirus Disease 2019 (COVID-19)-Positive Patients. Arch Pathol Lab Med. 2021. PMID: 33961007. doi:10.5858/arpa.2021-0137-SA

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。